Eckhard Thiel

21.5k total citations · 4 hit papers
260 papers, 11.9k citations indexed

About

Eckhard Thiel is a scholar working on Immunology, Hematology and Molecular Biology. According to data from OpenAlex, Eckhard Thiel has authored 260 papers receiving a total of 11.9k indexed citations (citations by other indexed papers that have themselves been cited), including 77 papers in Immunology, 74 papers in Hematology and 67 papers in Molecular Biology. Recurrent topics in Eckhard Thiel's work include Lymphoma Diagnosis and Treatment (62 papers), Acute Lymphoblastic Leukemia research (51 papers) and CNS Lymphoma Diagnosis and Treatment (50 papers). Eckhard Thiel is often cited by papers focused on Lymphoma Diagnosis and Treatment (62 papers), Acute Lymphoblastic Leukemia research (51 papers) and CNS Lymphoma Diagnosis and Treatment (50 papers). Eckhard Thiel collaborates with scholars based in Germany, United States and Switzerland. Eckhard Thiel's co-authors include Ulrich Keilholz, Carmen Scheibenbogen, Agnieszka Korfel, Thomas Schneider, Gero Hütter, Dirk Nagorsen, Kristina Allers, Igor Wolfgang Blau, Jörg Hofmann and Christoph Loddenkemper and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Blood.

In The Last Decade

Eckhard Thiel

257 papers receiving 11.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Long-Term Control of HIV by CCR5 Delta32/Delta32 Stem-Cell Transplantation

2009 1.3k citations Gero Hütter, Daniel Nowak et al. profile →
Report of an International Workshop to Standardize Baseline Evaluation and Response Criteria for Primary CNS Lymphoma

2005 582 citations Agnieszka Korfel, Eckhard Thiel et al. profile →
Establishment of a human cell line (mono mac 6) with characteristics of mature monocytes

1988 509 citations Eckhard Thiel et al. International Journal of Cancer profile →
Evidence for the cure of HIV infection by CCR5Δ32/Δ32 stem cell transplantation

2010 500 citations Kristina Allers, Gero Hütter et al. Blood profile →

Peers

Countries citing papers authored by Eckhard Thiel

Since Specialization

Citations

This map shows the geographic impact of Eckhard Thiel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eckhard Thiel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eckhard Thiel more than expected).

Fields of papers citing papers by Eckhard Thiel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eckhard Thiel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eckhard Thiel. The network helps show where Eckhard Thiel may publish in the future.

Co-authorship network of co-authors of Eckhard Thiel

This figure shows the co-authorship network connecting the top 25 collaborators of Eckhard Thiel. A scholar is included among the top collaborators of Eckhard Thiel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eckhard Thiel. Eckhard Thiel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Patients with Primary Central Nervous System Lymphoma Not Eligible for Clinical Trials: Prognostic Factors, Treatment and Outcome 2021 ·Cancers ·Sabine Seidel, (unknown), Thomas E. Kowalski, Alexander Baraniskin, Roland Schroers, Agnieszka Korfel, Eckhard Thiel, Michael Weller, Peter Martus, Uwe Schlegel	3
2	Erroneous class switching and false VDJ recombination: Molecular dissection of t(8;14)/MYC‐IGH translocations in Burkitt‐type lymphoblastic leukemia/B‐cell lymphoma 2013 ·Molecular Oncology ·Thomas Burmeister, Mara Molkentin, Stefan Schwartz, Nicola Gökbuget, Dieter Hoelzer, Eckhard Thiel, Richard Reinhardt	18
3	Evidence for the cure of HIV infection by CCR5Δ32/Δ32 stem cell transplantation breakdown → 2010 ·Blood ·Kristina Allers, Gero Hütter, Jörg Hofmann, Christoph Loddenkemper, Kathrin Rieger, Eckhard Thiel, Thomas Schneider	500
4	Transcriptional down-regulation of the Wnt antagonist SFRP1 in haematopoietic cells of patients with different risk types of MDS 2010 ·Leukemia Research ·(unknown), Maximilian Mossner, Martín Neumann, Uwe Platzbecker, Christiane Schumann, Eckhard Thiel, Wolf‐Karsten Hofmann	31
5	In vitro cytotoxicity of the novel antimyeloma agents perifosine, bortezomib and lenalidomide against different cell lines 2010 ·Investigational New Drugs ·Martin Schmidt‐Hieber, (unknown), Andreas Weimann, Babette Aicher, Philipp Lohneis, Antonia Busse, Eckhard Thiel, Igor Wolfgang Blau	9
6	Central Nervous System Disease in Hematologic Malignancies: Historical Perspective and Practical Applications 2009 ·Seminars in Oncology ·Ching‐Hon Pui, Eckhard Thiel	116
7	Central nervous system infections in immunocompromised patients – update on diagnostics and therapy 2008 ·Leukemia & lymphoma ·Martin Schmidt‐Hieber, Janine Zweigner, Lutz Uharek, Igor W. Blau, Eckhard Thiel	31
8	Targeted Therapy and Blood-Brain Barrier 2007 ·PubMed ·Agnieszka Korfel, Eckhard Thiel	7
9	Antibody Therapy in Non-Hodgkin’s Lymphoma: The Role of Rituximab, 90Y-Ibritumomab Tiuxetan, and Alemtuzumab 2007 ·PubMed ·Thomas Fietz, Eckhard Thiel	8
10	Phase I Trial of the Trifunctional Anti-HER2 × Anti-CD3 Antibody Ertumaxomab in Metastatic Breast Cancer 2006 ·Clinical Cancer Research ·Philipp Kiewe, Stephan Hasmüller, Steffen Kahlert, (unknown), Brigitte Rack, Alexander Marmé, Agnieszka Korfel, Michael Jäger, Horst Lindhofer, Harald Sommer, Eckhard Thiel, Michael Untch	139
11	Addition of GM-CSF to a peptide/KLH vaccine results in increased frequencies of CXCR3-expressing KLH-specific T cells 2006 ·Cancer Immunology Immunotherapy ·Il‐Kang Na, Ulrich Keilholz, Anne Letsch, Sandra Bauer, Anne Marie Asemissen, Dirk Nagorsen, Eckhard Thiel, Carmen Scheibenbogen	8
12	Mutation Analysis of hCDC4 in AML Cells Identifies a New Intronic Polymorphism 2006 ·International Journal of Medical Sciences ·Daniel Nowak, Maximilian Mossner, Claudia D. Baldus, Olaf Hopfer, Eckhard Thiel, Wolf‐Karsten Hofmann	11
13	Value of Surveillance Blood Cultures in Neutropenic Patients - A Pilot Study 2005 ·Japanese Journal of Infectious Diseases ·Olaf Penack, (unknown), Eckhard Thiel, Igor Wolfgang Blau	8
14	Empirical antimicrobial monotherapy in patients after high‐dose chemotherapy and autologous stem cell transplantation: a randomised, multicentre trial 2005 ·British Journal of Haematology ·(unknown), Oliver A. Cornely, Michael Sandherr, Thomas Kubin, Stefan W. Krause, Hermann Einsele, Eckhard Thiel, (unknown), Bernd Dörken, Georg Maschmeyer	25
15	Response to chemotherapy and treating institution predict survival in primary central nervous system lymphoma 2004 ·British Journal of Haematology ·Agnieszka Korfel, Peter Martus, Mohammad R. Nowrousian, Dieter K. Hossfeld, Heinz Kirchen, (unknown), Matthias Stelljes, Josef Birkmann, Christian Peschel, R. Pasold, Lars Fischer, Kristoph Jahnke, Eckhard Thiel, (unknown)	41
16	Functional CCR9 Expression Is Associated with Small Intestinal Metastasis 2004 ·Journal of Investigative Dermatology ·Anne Letsch, Ulrich Keilholz, Dirk Schadendorf, (unknown), Anne Marie Asemissen, Eckhard Thiel, Carmen Scheibenbogen	70
17	Common clonal T‐cell origin in a patient with T‐prolymphocytic leukaemia and associated cutaneous T‐cell lymphomas 2003 ·British Journal of Haematology ·Chalid Assaf, Michael Hummel, Edgar Dippel, Stefan Schwartz, Christoph C. Geilen, Lana Harder, Reiner Siebert, Matthias Steinhoff, Claus‐Detlev Klemke, Eckhard Thiel, Sergij Goerdt, Harald Stein, Constantin E. Orfanos	16
18	Possible regulation of Wilms’ tumour gene 1 (WT1) expression by the paired box genes PAX2 and PAX8 and by the haematopoietic transcription factor GATA‐1 in human acute myeloid leukaemias 2003 ·British Journal of Haematology ·Jan Siehl, Eckhard Thiel, (unknown), Emilian Snarski, Stefan Schwartz, Volker Mailänder, Ulrich Keilholz	25
19	De novo expression of the α5β1-fibronectin receptor in HT29 colon-cancer cells reduces activity of c-src. Increase of c-src activity by attachment on febronectin 1998 ·International Journal of Cancer ·Roland Schmidt, Michael Streit, Rolf Kaiser, Frank Herzberg, Michael Schirner, (unknown), Christine Kaufmann, Maren Henneken, Monika Schäfer‐Korting, Eckhard Thiel, (unknown)	17
20	Prognostic significance of additional chromosome abnormalities in adult patients with Philadelphia chromosome positive acute lymphoblastic leukaemia 1996 ·British Journal of Haematology ·Harald Rieder, Wolfgang Ludwig, W. Gaßmann, Jürgen Mäurer, Johannes W.G. Janssen, Nicola Gökbuget, Stefan Schwartz, Eckhard Thiel, Helmut Löffler, Claus R. Bartram, Dieter Hoelzer, Christa Fonatsch	62

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact